Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-15

FDA Approved: LEVOCARNITINE — Supplemental Application (American Regent, Inc.)

View source ↗

Summary

FDA approved a supplemental application for levocarnitine by American Regent, Inc. under ANDA 075861, indicating a regulatory action on this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVOCARNITINE (levocarnitine)

Snippet

SUPPL AP for LEVOCARNITINE (LEVOCARNITINE)